 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Pranidipine" – news ·newspapers ·books ·scholar ·JSTOR(February 2013) (Learn how and when to remove this message) |
 | |
| Names | |
|---|---|
| Preferred IUPAC name Methyl (2E)-3-phenylprop-2-en-1-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
| Other names 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acidO5-methylO3-[(E)-3-phenylprop-2-enyl] ester | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| MeSH | C048161 |
| UNII | |
| |
| |
| Properties | |
| C25H24N2O6 | |
| Molar mass | 448.46786 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Pranidipine is acalcium channel blocker. It is a long acting calcium channel antagonist of thedihydropyridine group.[1]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |
